Enveda
Business Services · Colorado, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
5700 Flatiron Pkwy, Boulder, Colorado, 8...Website
www.enveda.comRevenue
$68.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
4
1
1
About Enveda
Enveda is a biotechnology company that is learning from lifes chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organismsthe vast majority of which have never been explored by sciencecreating a database of chemical biodiversity: the library of life. By growing, organizing, translating, and searching this unique library, Enveda learns from lifes evolved solutions to address todays pressing medical needs.Explore more
Enveda Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enveda your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Enveda is spiking on competitors!
Click to see if Enveda had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Enveda recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Enveda
Product Launch: Get notified when Enveda launches new products
Funding: Get notified immidiatlly once Enveda has new funding data
Enveda, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Enveda has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Enveda
Find more new buyers
Company Profile Activity
Activity Insights
Enveda is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Enveda is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Enveda.
Enveda financials insights
Gather financial insights about Enveda, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series C
$150M
Series D
$150M
Enveda Tech Stack
A closer look at the technologies used by Enveda
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Enveda News & Media
Biotech's latest unicorn uses AI to mine nature's medicine chest - The Spokesman-Review
Nature is a prolific pharmacist. Aspirin, the blood thinner warfarin and metformin for diabetes all trace back to plants, discovered by serendipity before being transformed into drugs by modern chemistry.Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in ...
BOULDER, Colo., September 04, 2025--Enveda raises $150M Series D, reaches unicorn status, enrolls first patient in clinical trials, and adds former Pfizer CSO Mikael Dolsten to board.Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis
BOULDER, Colo.--(BUSINESS WIRE)-- #AI--Enveda, a clinical-stage biotechnology company pioneering the use of AI to unlock the therapeutic potential of life’s chemistry, today announced the successful completion of its Phase 1 clinical trial of ENV-294, a novel oral therapeutic for atopic dermatitis, asthma, and beyond. ENV-294 is a first-in-class anti-inflammatory small molecule derived from chemistry unearthed by Enveda’s platform. Based on the favorable safety and tolerability results in healthEnveda Receives Investment from Sanofi; Brings Total Series C Financing to $150M
Enveda, a Boulder, CO-based biotechnology company empowering life’s chemistry to discover new medicines, received an investment from Sanofi, bringing the total of Series C funding to $150M. Envada had announced a $130M Series C funding in November 2024. The company intends to use the funds to expand its clinical pipeline further in 2025, enhance its AI-driven […] The post Enveda Receives Investment from Sanofi; Brings Total Series C Financing to $150M appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enveda
Sign Up For FreeTo access detailed company insights
Enveda is a biotechnology company that is learning from lifes chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organismsthe vast majority of which have never been explored by sciencecreating a database of chemical biodiversity: the library of life. By... Read More
